BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29673080)

  • 1. Systemic sclerosis and malignancy.
    Sargin G; Senturk T; Cildag S
    Int J Rheum Dis; 2018 May; 21(5):1093-1097. PubMed ID: 29673080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignancies associated with systemic sclerosis.
    Szekanecz É; Szamosi S; Horváth Á; Németh Á; Juhász B; Szántó J; Szücs G; Szekanecz Z
    Autoimmun Rev; 2012 Oct; 11(12):852-5. PubMed ID: 22410174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-PM-Scl antibody in patients with systemic sclerosis.
    Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and causes of death in a Swedish series of systemic sclerosis patients.
    Hesselstrand R; Scheja A; Akesson A
    Ann Rheum Dis; 1998 Nov; 57(11):682-6. PubMed ID: 9924211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis.
    Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G
    Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study.
    Ghrénassia E; Avouac J; Khanna D; Derk CT; Distler O; Suliman YA; Airo P; Carreira PE; Foti R; Granel B; Berezne A; Cabane J; Ingegnoli F; Rosato E; Caramaschi P; Hesselstrand R; Walker UA; Alegre-Sancho JJ; Zarrouk V; Agard C; Riccieri V; Schiopu E; Gladue H; Steen VD; Allanore Y
    J Rheumatol; 2014 Jan; 41(1):99-105. PubMed ID: 24293584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ; Bannert B; Vonk M; Airò P; Cozzi F; Carreira PE; Bancel DF; Allanore Y; Müller-Ladner U; Distler O; Iannone F; Pellerito R; Pileckyte M; Miniati I; Ananieva L; Gurman AB; Damjanov N; Mueller A; Valentini G; Riemekasten G; Tikly M; Hummers L; Henriques MJ; Caramaschi P; Scheja A; Rozman B; Ton E; Kumánovics G; Coleiro B; Feierl E; Szucs G; Von Mühlen CA; Riccieri V; Novak S; Chizzolini C; Kotulska A; Denton C; Coelho PC; Kötter I; Simsek I; de la Pena Lefebvre PG; Hachulla E; Seibold JR; Rednic S; Stork J; Morovic-Vergles J; Walker UA
    Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative.
    van den Hoogen F; Khanna D; Fransen J; Johnson SR; Baron M; Tyndall A; Matucci-Cerinic M; Naden RP; Medsger TA; Carreira PE; Riemekasten G; Clements PJ; Denton CP; Distler O; Allanore Y; Furst DE; Gabrielli A; Mayes MD; van Laar JM; Seibold JR; Czirjak L; Steen VD; Inanc M; Kowal-Bielecka O; Müller-Ladner U; Valentini G; Veale DJ; Vonk MC; Walker UA; Chung L; Collier DH; Ellen Csuka M; Fessler BJ; Guiducci S; Herrick A; Hsu VM; Jimenez S; Kahaleh B; Merkel PA; Sierakowski S; Silver RM; Simms RW; Varga J; Pope JE
    Ann Rheum Dis; 2013 Nov; 72(11):1747-55. PubMed ID: 24092682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.
    Andréasson K; Saxne T; Bergknut C; Hesselstrand R; Englund M
    Ann Rheum Dis; 2014 Oct; 73(10):1788-92. PubMed ID: 23897770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE; Almodovar R; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2010 Feb; 39(4):285-93. PubMed ID: 19782387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan.
    Kuo CF; See LC; Yu KH; Chou IJ; Tseng WY; Chang HC; Shen YM; Luo SF
    Scand J Rheumatol; 2011; 40(5):373-8. PubMed ID: 21388247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.
    Barnes J; Mayes MD
    Curr Opin Rheumatol; 2012 Mar; 24(2):165-70. PubMed ID: 22269658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
    Scalapino K; Arkachaisri T; Lucas M; Fertig N; Helfrich DJ; Londino AV; Steen VD; Medsger TA
    J Rheumatol; 2006 May; 33(5):1004-13. PubMed ID: 16583463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of survival and causes of death in Japanese patients with systemic sclerosis.
    Hashimoto A; Tejima S; Tono T; Suzuki M; Tanaka S; Matsui T; Tohma S; Endo H; Hirohata S
    J Rheumatol; 2011 Sep; 38(9):1931-9. PubMed ID: 21765111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.
    Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of male sex on survival in systemic sclerosis.
    Hussein H; Lee P; Chau C; Johnson SR
    J Rheumatol; 2014 Nov; 41(11):2193-200. PubMed ID: 25274896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival and death causes in 251 systemic sclerosis patients from a single Italian center].
    Vettori S; Cuomo G; Abignano G; Iudici M; Valentini G
    Reumatismo; 2010; 62(3):202-9. PubMed ID: 21052567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.